A panel of experts review two patient cases to elucidate data in the adjuvant setting of non–small cell lung cancer.
EP. 8: Patient Profile 2: EGFR Exon 19 Deletion–Positive NSCLCMay 20th 2022
Shared insight on the diagnosis and management of EGFR exon 19 deletion–positive NSCLC, with regard for the potential of osimertinib in this setting.
EP. 9: Targeted and IO Therapy in EGFR Exon 19 Deletion–Positive NSCLCMay 27th 2022
Experts consider when and if it would be appropriate to utilize targeted or immunotherapy in patients with EGFR exon 19 deletion–positive NSCLC.
EP. 10: Future Perioperative Strategies in Non-Small Cell Lung CancerMay 27th 2022
Before closing out their discussion on non–small cell lung cancer, experts share excitement for possible improvements in the setting of perioperative therapy.